Join us as we transform immunology and deliver medicines that help autoimmune patients get their lives back. argenx is preparing for multi-dimensional expansion to reach more patients through a rich pipeline of differentiated assets, led by VYVGART, our first-in-class neonatal Fc receptor blocker approved for the treatment of gMG, and with the potential to treat patients across dozens of severe autoimmune diseases.

We are building a new kind of biotech company, one that maintains its roots as a science-based start-up and pushes our commitment to innovate across all corners of our business. We strive to inspire and grow our company, our partnerships, our science, and our people, because when we do, we deliver more for patients.

We are seeking a Manager of Investor Relations to support and drive argenx's communication strategy with investors, analysts, and other key stakeholders. The ideal candidate will have a solid understanding of the biotech industry, strong analytical and writing skills, and experience in problem-solving within a fast-paced environment. The Manager will work directly with the U.S. and European IR Leads (within the broader Integrated Communications and IR team) to support all investor related activities, while streamlining processes to contribute to the overall efficiency and growth of the team.

Roles and Responsibilities:

• Prepare materials for investor meetings, data readouts, earnings, and other external communications, ensuring clarity, consistency, and alignment with argenx's investment narrative. Role will require a significant amount of writing initial draft materials for all key investor communications




• Support the development and maintenance of argenx's key investor and analyst relationships




• Work closely with the team to identify and track key shareholder targets, ensuring optimal corporate access exposure




• Assist in the coordination of investor events, including earnings calls, conferences, investor days, and meetings with institutional investors




• Evaluate covering analyst models versus internal projections, identifying opportunities to streamline and automate data collection with software available




• Analyze competitor activities and data to provide insights to senior leadership and inform investor communication strategies




• Collaborate with the team and members of management to address investor concerns, develop messaging for key events, and craft strategies to respond to market dynamics and financial questions




• Support stewardship engagement relationship management to evaluate investor ESG focus areas




• Assist with the IR-component of the annual report, collaborating cross-functionally

Skills and Competencies:

• Advanced Microsoft Excel abilities required given expectation to work on consensus; (Data analysis, organization, and project tracking, etc.) Fluency in Microsoft PowerPoint required




• Strong problem-solving abilities and attention to detail




• Exceptional analytical skills with the ability to identify trends, draw insights, and make data driven recommendations




• Excellent verbal and written communication skills, with the ability to distill complex scientific and financial information for diverse audiences (both internal and external)




• High level of professionalism, discretion, and the ability to manage sensitive information




• Ability to manage multiple projects simultaneously and thrive in a fast-paced, deadline-driven environment




• Must be a strong team player - works well with others in a collaborative setting

Education, Experience and Qualifications:

• Bachelor's degree in Finance, Business, Life Sciences, or a related field. An MBA, PhD, or advanced degree is a plus




• 3-5 years of experience in Investor Relations, Banking, Corporate Finance, or a similar role within the biotechnology or pharmaceutical industry. Prior Investor Relations experience is preferred




• Strong experience with excel-based analysis, and creating presentations for investors and senior leadership




• A foundational understanding of the biotech sector and investor dynamics




• Prior experience writing financial communications within a biotech or pharma setting is a plus (earnings scripts, press releases, etc.)

#LI-Hybrid

At argenx, all applicants are welcomed in an inclusive environment. They will receive equal consideration for employment without discrimination on the basis of race, color, religion, sex, sexual orientation, gender identity, national origin, protected veteran status, disability, or any other applicable legally protected characteristics. argenx is proud to be an equal opportunity employer.

If you require reasonable accommodation in completing your application, interviewing, or otherwise participating in the candidate selection process please contact us at hr.us@argenx.com. Only inquiries related to an accommodation request will receive a response.